The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: The Circulatory Risk in Communities Study (CIRCS)
Abstract
Background Non-fasting triglycerides were reported to have a greater impact on risk of ischemic cardiovascular events than fasting triglycerides. However, evidence from Asia, where the prevalence of dyslipidemia is generally lower, has been limited.Methods We used 1975-1986 baseline surveys to investigate cohort data of 10,659 (4264 men and 6395 women) residents aged 40-69 years, initially free from ischemic heart disease and stroke, in four Japanese communities. Serum triglyceride concentrations at baseline were obtained for 2424 fasting (≥8 h after meal) and 8235 non-fasting (<8 h after meal) participants.Results During the 22-year follow-up, 284 (165 men and 119 women) developed ischemic heart disease and 666 (349 men and 317 women) ischemic stroke. After adjustment for age, sex and known cardiovascular risk factors, multivariable hazard ratios (95%CI) of ischemic cardiovascular disease (ischemic heart disease and ischemic stroke) for the highest versus lowest quartiles of triglycerides were 1.71 (1.14-2.59), P for trend = 0.013, for fasting participants and 1.60 (1.25-2.05), P for trend <0.001, for non-fasting participants. The positive associations did not differ between fasting and non-fasting men, while they were strong for non-fasting women. They were stronger for ischemic heart disease than for ischemic stroke. After further adjustment for HDL-cholesterol, these associations were slightly attenuated, but remained statistically significant.Conclusion Non-fasting as well as fasting triglycerides are predictive of risk of ischemic cardiovascular disease for Japanese men, as are non-fasting triglycerides for women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been shown in epidemiological surveys in Japan that the occurrence of CAD increases when fasting TG levels of are ≥ 150 mg/dL46, 90).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [90]
Citations
Cites
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Stampfer, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03540110036029 · Cited by 1,081
Recommendations for Human Blood Pressure Determination by Sphygmomanometers
Kirkendall, W. M., Burton, A. C., Epstein, F. H., & Freis, E. D. (1967) · Circulation · doi:10.1161/01.cir.36.6.980 · Cited by 882
Graaf, J. D., Hak-Lemmers, H. L. M., Hectors, M. P. C., Demacker, P. N. M., Hendriks, J. C. M., & Stalenhoef, A. F. H. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 719
Cited by
Sorted by citations
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0133 · Cited by 565
Hypertriglyceridaemia and risk of coronary artery disease
Reiner, Ž. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.31 · Cited by 390
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 345
Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
Hiyoshi, T., Fujiwara, M., & Zemin, Y. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160164 · Cited by 112
Yamashita, S., Masuda, D., & Matsuzawa, Y. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48918 · Cited by 71
Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke?
Liang, H., Zhang, Q., Hu, Y., Liu, G., & Qi, R. (2022) · Journal of Stroke · doi:10.5853/jos.2021.02831 · Cited by 74
Yamagishi, K., Muraki, I., Kubota, Y., Hayama‐Terada, M., Imano, H., Cui, R., Umesawa, M., Shimizu, Y., Sankai, T., Okada, T., et al. (2018) · Journal of Epidemiology · doi:10.2188/jea.je20180196 · Cited by 57
Self-citationNaiberg, M. R., Newton, D. F., Collins, J. E., Dickstein, D. P., Bowie, C. R., & Goldstein, B. I. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12603 · Cited by 56
Hansson, P., Holven, K. B., Øyri, L. K. L., Brekke, H. K., Biong, A. S., Gjevestad, G. O., Raza, G. S., Herzig, K., Thoresen, M., & Ulven, S. M. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy291 · Cited by 60
Higashiyama, A., Wakabayashi, I., Okamura, T., Kokubo, Y., Watanabe, M., Takegami, M., Honda-Kohmo, K., Okayama, A., & Miyamoto, Y. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.62730 · Cited by 52
JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease
Fujiyoshi, A., Kohsaka, S., Hata, J., Hara, M., Kai, H., Masuda, D., Miyamatsu, N., Nishio, Y., Ogura, M., Sata, M., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0285 · Cited by 55
Iso, H., Cui, R., Takamoto, I., Kiyama, M., Saito, I., Okamura, T., Miyamoto, Y., Higashiyama, A., Kiyohara, Y., Ninomiya, T., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.020760 · Cited by 42
Self-citationSuzuki, K., Oikawa, T., Nochioka, K., Miura, M., Kasahara, S., Sato, M., Aoyanagi, H., Shiroto, T., Takahashi, J. A., Miyata, S., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312336 · Cited by 35
Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
Doi, T., Langsted, A., & Nordestgaard, B. G. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22013 · Cited by 37
Different Patterns of Walking and Postprandial Triglycerides in Older Women
Kashiwabara, K., Kidokoro, T., Yanaoka, T., Burns, S. F., Stensel, D. J., & Miyashita, M. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001413 · Cited by 29
Leung, G. K. W., Davis, R., Huggins, C. E., Ware, R. S., & Bonham, M. P. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.03.008 · Cited by 28
Kohata, Y., Ohara, M., Nagaike, H., Fujikawa, T., Osaka, N., Goto, S., Fukase, A., Kushima, H., Hiromura, M., Terasaki, M., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00772-7 · Cited by 29
Relationship between triglyceride levels and ischaemic stroke in elderly hypertensive patients
Huang, Y., Huang, J., Liu, L., Chen, C., Yu, Y., Tang, S., Zhang, B., & Feng, Y. (2019) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2019-136961 · Cited by 28
Tada, H., Nomura, A., Yoshimura, K., Itoh, H., Komuro, I., Yamagishi, M., Takamura, M., & Kawashiri, M. (2020) · Circulation Journal · doi:10.1253/circj.cj-19-0981 · Cited by 26
Nakamura, M., Iso, H., Kitamura, A., Imano, H., Noda, H., Kiyama, M., Sato, S., Yamagishi, K., Nishimura, K., Nakai, M., et al. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215624461 · Cited by 26
Self-citationSeaweed Intake and Risk of Cardiovascular Disease: The Circulatory Risk in Communities Study (CIRCS)
Chichibu, H., Yamagishi, K., Kishida, R., Maruyama, K., Hayama‐Terada, M., Shimizu, Y., Muraki, I., Umesawa, M., Cui, R., Imano, H., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.61390 · Cited by 22
Self-citationTriglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy
Reiner, Ž. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0343 · Cited by 19
Lipids, Apolipoproteins, and Inflammatory Biomarkers of Cardiovascular Risk: What Have We Learned?
Rhainds, D., Brodeur, M. R., & Tardif, J. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1114 · Cited by 19
Chen, Y., Lei, K., Liu, Y., Liu, J., Wei, K., Guo, J., & Su, Z. (2025) · Biomolecules · doi:10.3390/biom15070990 · Cited by 20
Takao, T., Suka, M., Yanagisawa, H., & Kasuga, M. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13403 · Cited by 16
Cheng, Q., Zhou, D., Wang, J.-B., Nie, Z., Feng, X., Huang, Y., Liang, Q., & Feng, Y. (2022) · Clinical Cardiology · doi:10.1002/clc.23931 · Cited by 17
Grant, D. M., Tomlinson, D. J., Tsintzas, K., Kolić, P. V., & Onambélé-Pearson, G. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.574595 · Cited by 20
Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease?
Reiner, Ž. (2015) · Cardiology · doi:10.1159/000381304 · Cited by 17
Sabaka, P., Kruzliak, P., Balaz, D., Komornikova, A., Celovska, D., Cammarota, G., Kusendova, K., Bendzala, M., Rodrigo, L., Dukat, A., et al. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0148-5 · Cited by 16
Kiyosue, A. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.09.001 · Cited by 16
Takeda, Y., Sakuma, I., Hiramitsu, S., Okada, M., Ueda, S., & Sakurai, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1094100 · Cited by 15
Arifuddin, A., Buana, G. S., Vinarti, R. A., & Djunaidy, A. (2024) · Procedia Computer Science · doi:10.1016/j.procs.2024.03.048 · Cited by 14
Zhou, H., Zhang, S., Sun, X., Yang, D.-Y. D., Zhuang, X., Guo, Y., Hu, X. Y., Du, Z., Zhang, M., & Liao, X. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.07.71 · Cited by 14
Changes in ischaemic ECG abnormalities and subsequent risk of cardiovascular disease
Sawai, T., Imano, H., Muraki, I., Hayama‐Terada, M., Shimizu, Y., Cui, R., Kitamura, A., Kiyama, M., Okada, T., Ohira, T., et al. (2017) · Heart Asia · doi:10.1136/heartasia-2016-010846 · Cited by 14
Self-citationHirata, A., Okamura, T., Hirata, T., Sugiyama, D., Ohkubo, T., Okuda, N., Kita, Y., Hayakawa, T., Kadota, A., Kondo, K., et al. (2021) · Journal of Epidemiology · doi:10.2188/jea.je20200399 · Cited by 17
Tanimura‐Inagaki, K., Nagao, M., Harada, T., Sugihara, H., Moritani, S., Sasaki, J., Kono, S., & Oikawa, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108119 · Cited by 15
Non-fasting lipids detection and their significance in pregnant women
Li, Y., He, J., Zeng, X., Zhao, S., Wang, X., & Yuan, H. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1038-z · Cited by 12
Triglycerides as Residual Risk for Atherosclerotic Cardiovascular Disease
Ohmura, H. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0239 · Cited by 12
Furuya, C., Hashimoto, Y., Morishita, S., Inano, T., Ochiai, T., Shirane, S., Edahiro, Y., Araki, M., Ando, M., & Komatsu, N. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02751-0 · Cited by 11
The roles ofMMP8/MMP10polymorphisms in ischemic stroke susceptibility
Zhao, Y., Zhang, Q., Zhang, X., Zhang, Y., Lu, Y., Ma, X., Li, W., Niu, X., Zhang, G., Chang, M., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2797 · Cited by 10
Sekizuka, H., Hoshide, S., Kabutoya, T., & Kario, K. (2021) · International Heart Journal · doi:10.1536/ihj.21-309 · Cited by 9
Ren, Z., Guo, J., Xiao, X., Huang, J., Li, M., Cai, R., & Zeng, H. (2020) · Cardiology Research and Practice · doi:10.1155/2020/2132918 · Cited by 10
Imano, H., Li, J., Tanaka, M., Yamagishi, K., Muraki, I., Umesawa, M., Kiyama, M., Kitamura, A., Sato, S., & Iso, H. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63358 · Cited by 9
Self-citationOkada, C., Imano, H., Yamagishi, K., Cui, R., Umesawa, M., Maruyama, K., Muraki, I., Hayama‐Terada, M., Shimizu, Y., Sankai, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.44438 · Cited by 9
Self-citationSugiura, T., Dohi, Y., Takase, H., Yamashita, S., Tsuzuki, Y., Ogawa, S., Tanaka, Y., & Ohte, N. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.08.008 · Cited by 9
Yamagishi, K., Iso, H., Sairenchi, T., Irie, F., Takizawa, N., Koba, A., Tomizawa, T., & Ota, H. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63081 · Cited by 8
Self-citationUtility of metabolic syndrome as a risk enhancing factor in decision of statin use
Vega, G. L., Wang, J., & Grundy, S. M. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.01.012 · Cited by 8
Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study
Iwasaki, M., Suzuki, H., Umezawa, Y., Koshida, T., Saito, M., Fukuda, H., Takahara, H., Matsuzaki, K., & Suzuki, Y. (2023) · Medicine · doi:10.1097/md.0000000000032818 · Cited by 10
Beyond the Guidelines: Perspectives on Management of Pediatric Patients with Hypertriglyceridemia
Gagnon, C. A., & Ashraf, A. P. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01237-z · Cited by 9
Seki, M., Nakano, T., Tanaka, S., Kitamura, H., Hiyamuta, H., Ninomiya, T., Tsuruya, K., & Kitazono, T. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64625 · Cited by 7
Triglycerides and the Risk of Atherosclerotic Cardiovascular Events Across Different Risk Categories
Mizuta, H., Ishii, M., Ikebe, S., Otsuka, Y., Yamanouchi, Y., Nakamura, T., & Tsujita, K. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65334 · Cited by 8
A non-fasting marker of metabolic syndrome in a high-risk population
Cancelliere, S., Heung, T., Blagojevic, C., Malecki, S. L., Dash, S., & Bassett, A. S. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100573 · Cited by 7
Miura, Y., Kanamaru, H., Yasuda, R., Toma, N., & Suzuki, H. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.09.091 · Cited by 7
Cardiovascular risk and blood pressure lowering treatment among elderly individuals
Asayama, K., Ohkubo, T., Satoh, A., Tanaka, S., Higashiyama, A., Murakami, Y., Yamada, M., Saitoh, S., Okayama, A., Miura, K., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001555 · Cited by 7
Miyashita, M., Hamada, Y., Fujihira, K., Nagayama, C., Takahashi, M., Burns, S. F., Thackray, A. E., & Stensel, D. J. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02234-z · Cited by 7
Komatsu, T., Miura, T., Joko, K., Sunohara, D., Mochidome, T., Kasai, T., & Ikeda, U. (2021) · Internal Medicine · doi:10.2169/internalmedicine.6871-20 · Cited by 6
Gohar, A., Schnabel, R. B., Hughes, M., Zeller, T., Blankenberg, S., Pasterkamp, G., & den Ruijter, H. M. (2015) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcv028 · Cited by 6
Takeda, Y., Sakuma, I., Hiramitsu, S., Okada, M., Ueda, S., & Sakurai, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061360 · Cited by 4
Choe, H. J., Park, S. H., Han, K., Moon, M. K., & Koo, B. K. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.11.008 · Cited by 5
Katakura, Y., Shimoda, M., Ohnishi, M., Kusano, T., Dan, K., Isobe, H., Wamata, R., Iwamoto, Y., Fushimi, Y., Sanada, J., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.02.011 · Cited by 5
Peng, Y., Chen, G., & Zheng, H. (2020) · PubMed Central · doi:10.12122/j.issn.1673-4254.2020.08.11 · Cited by 4
Effects of Undaria pinnatifida (Wakame) on Postprandial Serum Lipid Responses in Humans
Yoshinaga, K., & Mitamura, R. (2019) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.72.267 · Cited by 4
The Benefits of Fasting to Improve Health Conditions and to Prevent Cardiovascular Disease
Samudera, W. S., Fernandez, G. V., Fitriyah, R., Arifin, H., Wulandari, S. M., & Permana, R. A. (2020) · Jurnal NERS · doi:10.20473/jn.v14i3.17168 · Cited by 7
Koyama, I., Imano, H., Nakamura, M., Kitamura, A., Kiyama, M., Miyamoto, Y., & Iso, H. (2020) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563220921884 · Cited by 4
Self-citationCui, M., Chiang, C., Cui, R., Honjo, K., Yatsuya, H., Watson, B. M., Ikerdeu, E., Mita, T., Madraisau, S., Aoyama, A., et al. (2018) · Journal of Epidemiology · doi:10.2188/jea.je20170127 · Cited by 5
Self-citationZhong, Z., Miyachi, M., & Tanisawa, K. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1454731 · Cited by 3
Li, G., He, L., Bai, X., Chen, S., Dai, H., He, G., Yang, Y., Zhang, X., Cui, J., Li, X., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101689 · Cited by 4
Mori, T., Murasaki, K., Hayashi, K., & Yokoyama, Y. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.06.007 · Cited by 3
Cui, M., Ikehara, S., Ueda, K., Yamagishi, K., Iso, H., & the Japan Environment and Children’s Study Group (2023) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.23-00008 · Cited by 4
Self-citationNagayama, C., Kohda, K., Hamada, Y., Kamemoto, K., Hiratsu, A., Tataka, Y., & Miyashita, M. (2020) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2020.12.002 · Cited by 2
Inhibition of lipid digestion by β-glucanase-treated Candida utilis
Kitahara, C., Sakurai, T., Furuta, K., & Katsumata, T. (2021) · Food Science and Technology Research · doi:10.3136/fstr.27.615 · Cited by 2
Omagari, K., UCHIDA, M., TAGAWA, Y., Yogo, M., INAGAKI, K., Hongo, R., Takeuchi, S., Suruga, K., Koba, K., Ichimura‐Shimizu, M., et al. (2022) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.68.409 · Cited by 2
Pemafibrate Improves Alanine Aminotransferase Levels Independently of Its Lipid-Lowering Effect
Watanabe, A., Horigome, R., Nakatsuka, Y., & Terai, S. (2023) · Livers · doi:10.3390/livers3040038 · Cited by 1
Shima, H., Tashiro, M., Inoue, T., Okada, K., Okamoto, T., Wariishi, S., Doi, T., & Minakuchi, J. (2024) · Cureus · doi:10.7759/cureus.57777 · Cited by 2
Bery, K., Alherk, M. A., Yahia, M. A. M. K., & Govindankutty, K. (2022) · Scholars Journal of Applied Medical Sciences · doi:10.36347/sjams.2022.v10i05.008 · Cited by 1
Triglycerides and Residual Risk of CVD
Higashiyama, A., & Fujiyoshi, A. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed283 · Cited by 1
Shimasaki, Y., & Nojima, M. (2025) · AJPM Focus · doi:10.1016/j.focus.2025.100380 · Cited by 1
Takahashi, K., Nishida, Y., Yokota, S., Tada, K., Hiyamuta, H., Ito, K., Yasuno, T., Maeda, T., Arima, H., & Masutani, K. (2023) · Kidney & Blood Pressure Research · doi:10.1159/000530506 · Cited by 1
Sezai, A., Tanaka, M., & 奥村, 恭. (2023) · Journal of Nihon University Medical Association · doi:10.4264/numa.82.2_71 · Cited by 1
KATO, K., Yokoyama, H., IWASAKI, T., KONNO, Y., Yamazaki, K., Shikanai, S., KATO, T., Tsushima, M., Senoo, M., NARITA, N., et al. (2024) · In Vivo · doi:10.21873/invivo.13792 · Cited by 2
Serum lipid management in patients with type 1 and type 2 diabetes: a hospital-based cohort study
Hasegawa, Y., Nakagami, T., Oya, J., Isago, C., Kurita, M., Tanaka, Y., Ito, A., Tsuzura, R., Hirota, N., Miura, J., et al. (2018) · Diabetology International · doi:10.1007/s13340-018-0365-z · Cited by 1
Teramoto, T., Ogawa, H., Ueshima, H., Okada, Y., Haze, K., Matsui, S., Fujikawa, K., Hashimoto, T., Sakui, S., Nishimura, K., et al. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2094914 · Cited by 1
Mori, T., Murasaki, K., & Yokoyama, Y. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.09.002 · Cited by 1
kuspriyanti, N. P., Lestari, D. N., & Kaniawati, S. (2022) · Jurnal Profesi Medika Jurnal Kedokteran dan Kesehatan · doi:10.33533/jpm.v16i2.4809 · Cited by 1
Tada, H., Takamura, M., & Kawashiri, M.-A. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed178 · Cited by 1
Ceri̇t, L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.100
VII. Triglyceride and HDL Cholesterol as Risk Factors and the Treatment Targets for Atherosclerosis
Ai, M. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.725
Dyslipidemia: Contemporary Therapy Options in Terms of Worldwide Guidelines
Djordjevic, D. B., Đorđević, A. D., & Lović, D. B. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00173-w
Lin, X. (2019) · The Atrium (University of Guelph)
Masuda, D. (2020) · Health Evaluation and Promotion · doi:10.7143/jhep.47.660
Bando, H., Taneda, S., & Manda, N. (2021) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.67.266
2) Epidemiologic Insights of Cerebrovascular Event in Japan
Iso, H. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.1851
Self-citationOptimal Cut-off Points of Triglycerides for Cardiovascular Disease Prediction in Japanese Population
Hirata, A. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed210
Nakamura, Y., Kabayama, M., Godai, K., Akasaka, H., Tseng, W., Yamamoto, K. I., Takami, Y., Takeya, Y., Gondo, Y., Yasumoto, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2480554/v1
Katahira, M., Imai, S., Ono, S., & Moriura, S. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0045 · Cited by 1
Tsukamoto, K. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.344
Yanai, H. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed277
Wasana, K. G. P., Silva, N. D. D., Attanayake, A. P., Weerarathna, T. P., & Wadasinghe, R. R. (2025) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2025-0062
Tsukamoto, K. (2025) · Health Evaluation and Promotion · doi:10.7143/jhep.52.353
Metadata
- Authors
- Iso, H., Imano, H., Yamagishi, K., Ohira, T., Cui, R., Noda, H., Sato, S., Kiyama, M., Okada, T., Hitsumoto, S., Tanigawa, T., & Kitamura, A.
- Affiliations
- The University of Osaka (JP)
- Osaka Center for Cancer and Cardiovascular Disease Prevention (JP)
- University of Tsukuba (JP)
- Chiba Prefectural Institute of Public Health (JP)
- Ehime University Hospital (JP)
- Ehime University (JP)
- ORCID
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 237
- Issue
- 1
- Pages
- 361-368
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W1977704640
- Cited by
- 104
- References
- 39
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 8 · 2023: 12 · 2022: 14 · 2021: 14 · 2020: 12 · 2019: 11 · 2018: 9 · 2017: 7 · 2016: 2 · 2015: 4
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (04304036, 02454209, 50223053, 06454234, 08457125, 10470103, 12470092, 19590629, 19590663, 15659146)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- fasting triglycerides, ischemic cardiovascular disease, ischemic heart disease, ischemic stroke, dyslipidemia, sex differences, HDL cholesterol, Japanese adults, Circulatory Risk in Communities Study
- MeSH terms
- Adult, Aged, Fasting, Female, Follow-Up Studies, Humans, Japan, Cholesterol, HDL, Male, Middle Aged, Risk Factors, Triglycerides, Multivariate Analysis, Proportional Hazards Models, Treatment Outcome, Myocardial Ischemia, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review